Back to Search Start Over

With FDA's inevitable rejection in hand for eye drug, Aldeyra plans speedy new trial.

Authors :
Armstrong, Annalee
Source :
FierceBiotech; 11/28/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Aldeyra Therapeutics had prepared for the worst and now it's here. The FDA has rejected the dry eye drug reproxalap. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
NEW trials
DRY eye syndromes
DRUGS

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
173947435

Tools

Authors Abstract Subjects Details